DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Full Year 2021 Financial Results and Highlights Operational Progress

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Annual Results/Annual Report Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N...

Related Keywords

Germany ,Taiwan ,Hong Kong ,Vijverberg ,Gelderland ,Netherlands ,United Kingdom ,China ,Switzerland ,Macao ,Macau General ,Macau ,Chinese ,Valeria Fisher ,Florian Schmid ,Ulrich Dauer ,Manuela Bader ,Michael Schaeffer ,International Financial Reporting Standards ,Drug Administration ,Trophic Communications ,Simcere Pharmaceutical Group Ltd ,International Journal Of Molecular Sciences Hoffmann ,Alzheimer Disease Cooperative Study ,Corporate Development ,Journal Alzheimer Research Therapy Vijverberg ,European Union ,National Medical Products Administration ,China Center ,International Accounting Standards Board ,National Institute On Aging ,Full Year ,Highlights Operational ,Euronext Amsterdam ,European Phase ,Fast Track ,Disease Cooperative Study ,National Institute ,Neuropsychological Test Battery ,Greater China ,Extraodinary General Meeting ,Director Finance ,Annual General Meeting ,Drug Evaluation ,Clinical Trial Application ,Non Executive Board ,General Meeting ,Mainland China ,Years Ended December ,Financial Position ,Shareholder Equity ,Cash Flows ,Financial Report ,Netherlands Civil ,